Skip To Main Content
Skip To Main Content

Continuing Pharmacy Education

Raabe College is committed to assuring that all students receive the finest education possible and is now offering continuing education to pharmacy professionals through distance learning methods. Our faculty members are dedicated scholars with a desire to assist student learning. We welcome your inquiries regarding the profession and our academic program. To learn more, click on any of the listings below.

The Ampul

General Continuing Education Programs

Rivaroxaban in the Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism (Expires 05/28/2017)
 

Venous thromboembolism (VTE) is comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE) and is a relatively common condition which often results in hospitalization. Treatment of acute VTE can typically be classified into two broad categories: acute and chronic anticoagulation therapy.  More...

Evolving Treatments in Hepatitis C (Expires 05/28/2017)

Since its identification in the 1980’s, the standard of care for hepatitis C virus (HCV) has included interferon therapy.1 Interferon treatment was combined with ribavirin in 1998. Poor efficacy rates, especially in genotype 1, along with an unfavorable adverse effect profile created an unpopular aura around HCV treatment. This protocol remained unchanged until 2011, when the release of HCV-specific protease inhibitors (boceprevir, telaprevir) revolutionized the effectiveness of HCV drug therapy.   More...

Canagliflozin (Invokana®) Inquiries (Expires 05/28/2017)

Diabetes is a significant and growing health problem in the United States that affects more than 25 million people.  Of these 25 million, approximately 18 million people are diagnosed with diabetes, while seven million people have undiagnosed diabetes.  More...

Drug interactions: a look at timing, genetic interplay and tips for recognizing and preventing them in clinical practice  (Expires 12/03/2016)

This is the evaluation site for the CE article "Drug interactions: a look at timing, genetic interplay and tips for recognizing and preventing them in clinical practice" found on the Genelex website (http://genelex.com/resources/CME/).  You may only receive credit once for this program.

 


PAW Review Evaluations


FDA Approves New Tuberculosis Drug: Sirturo® (bedaquiline) (Expires 05/17/2016)

This is the site link for the CE article "FDA Approves New Tuberculosis Drug: Sirturo® (bedaquiline)" found in the Raabe College of Pharmacy PAW Review.  You may only receive credit once for this program.  Make sure you complete the survey and quiz to receive credit.  Certificates will be issued through CPEMonitor.

Makena®: A drug for reducing the risk of preterm labor (Expires 05/17/2016)

This is the site link for the CE article "Makena®: A drug for reducing the risk of preterm labor" found in the Raabe College of Pharmacy PAW Review.  You may only receive credit once for this program.  Make sure you complete the survey and quiz to receive credit.  Certificates will be issued through CPEMonitor.
 

A Comparison of Mipomersen (Kynamro®) and Lomitapide (Juxtapid®): Medications for the Treatment of Homozygous Familial Hypercholesterolemia (Expires 02/25/2017)

This is the site link for the CE article "A Comparison of Mipomersen (Kynamro®) and Lomitapide (Juxtapid®): Medications for the Treatment of Homozygous Familial Hypercholesterolemia" found in the Raabe College of Pharmacy PAW Review.  You may only receive credit once for this program.  Make sure you complete the survey and quiz to receive credit.  Certificates will be issued through CPEMonitor.
 

Celiac Disease: Current and Investigational Therapies and the Role of the Pharmacist (Expires 02/25/2017)

This is the site link for the CE article "Celiac Disease: Current and Investigational Therapies and the Role of the Pharmacist" found in the Raabe College of Pharmacy PAW Review.  You may only receive credit once for this program.  Make sure you complete the survey and quiz to receive credit.  Certificates will be issued through CPEMonitor.

Neonatal Abstinence Syndrome: A Targeted Review for Pharmacists (Expires 05/06/2017)

This is the site link for the CE article "Neonatal Abstinence Syndrome: A Targeted Review for Pharmacists" found in the Raabe College of Pharmacy PAW Review.  You may only receive credit once for this program.  Make sure you complete the survey and quiz to receive credit.  Certificates will be issued through CPEMonitor.

Ibrutinib (IMBRUVICA) for Treatment of Mantle Cell Lymphoma (MCL) (Expires 05/07/2017)

This is the site link for the CE article "Ibrutinib (IMBRUVICA) for Treatment of Mantle Cell Lymphoma (MCL)" found in the Raabe College of Pharmacy PAW Review.  You may only receive credit once for this program.  Make sure you complete the survey and quiz to receive credit.  Certificates will be issued through CPEMonitor.

College of Pharmacy

419-772-2275
pharmacy@onu.edu
Robertson-Evans Pharmacy Building
525 South Main Street
Ada, Ohio 45810
Monday: 8 a.m.-5 p.m.
Tuesday: 8 a.m.-5 p.m.
Wednesday: 8 a.m.-5 p.m.
Thursday: 8 a.m.-5 p.m.
Friday: 8 a.m.-5 p.m.
Saturday: Closed
Sunday: Closed